Acitretin modulates keratinocyte differentiation and maturation for severe psoriasis. Through these regulatory effects, the compound decreases hyperproliferation of the epidermis, managing the clinical manifestation of recalcitrant dermatological conditions.
Targeting abnormal skin cell turnover, acitretin belongs to the retinoid family and serves as a systemic therapy for severe psoriasis. It acts as a synthetic analogue of vitamin A, influencing how skin cells mature and shed. The substance is the active compound found in medications such as Soriatane, which are approved for dermatological use.
Formulated as oral tablets, this retinoid appears in the Singapore market under the name Soriatane. Both branded and generic tablet versions are dispensed through pharmacies following health-authority approval. Patients receive the medication in standard dose packs, typically ranging from 10 mg to 25 mg per tablet.
Addressing persistent plaque formations, the compound is employed for several severe psoriasis variants, including plaque psoriasis, pustular psoriasis, and erythrodermic psoriasis. It also assists individuals with disorders of keratinisation such as congenital ichthyosis. Dermatologists often select this therapy when topical agents alone provide insufficient relief. The drug’s role expands to off-label use for rare hyperproliferative skin disorders when clinical judgment deems it appropriate.
Modulating the differentiation of epidermal cells, the drug reduces the speed at which skin layers proliferate. By normalising the balance between cell growth and shedding, it helps to flatten raised plaques and lessen scaling. The effect becomes noticeable after several weeks of continuous therapy, aligning skin renewal with healthier patterns.
Experiencing dry skin, cracked lips, or mild itching often occurs during the initial weeks. These sensations usually resolve with moisturising measures and regular use.
Developing severe skin peeling, unexplained vision changes, or persistent abdominal pain requires urgent medical attention. Such signs may indicate rare but important systemic effects.
Pregnant individuals and those with severe liver disease should avoid this medication. Additionally, patients with known hypersensitivity to retinoids are advised against its use.
Consuming alcohol or using other systemic retinoids may heighten the risk of liver strain. Patients should refer to their specific medication’s insert for a complete interaction list.
Storing the tablets in a cool, dry place preserves their potency throughout the prescribed course. Typical treatment periods range from several months for acute flare-ups to longer maintenance phases for chronic disease control. Variability exists between different brand formulations, influencing monitoring schedules. For detailed usage, dosing, and administration, refer to the specific medication's clinical information.
This overview provides educational information about acitretin, not medical advice, and individual medicines such as Soriatane differ in strength, formulation, and instructions. Liability for clinical application is disclaimed. Patients should consult their specific medication labeling and a licensed healthcare professional for personalized guidance.
